DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Voltaren (Diclofenac) - Adverse Event Reports - Hospitalization - C-Reactive Protein Increased

 



Index of reports > Cases resulting in hospitalization (196) > Cases with C-Reactive Protein Increased (22)

Below is the selection of adverse event reports related to Voltaren (Diclofenac) that includes cases resulting in hospitalization where reactions include c-reactive protein increased.

Adverse event in 85 year old female receiving Voltaren (Diclofenac)

Reported by a individual with unspecified qualification from Norway on 2007-10-29

Patient: 85 year old female

Adverse reactions / side effects: Tachycardia, Tricuspid Valve Incompetence, C-Reactive Protein Increased, Dyspepsia, Blood Creatinine Increased, White Blood Cell Count Increased, Anuria, Hiatus Hernia, Diastolic Dysfunction, Renal Cyst, Computerised Tomogram Abnormal, Organ Failure, Haemoglobin Decreased, Hepatic Cyst, Cardiac Failure, Mitral Valve Incompetence, Ejection Fraction Decreased, Peptic Ulcer Perforation

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Ibux
    Indication: Myalgia

Prednisolone
    Dosage: 10 mg/day
    Indication: Myalgia

Voltaren
    Indication: Myalgia

Other drugs received by patient: Zantac



Adverse event in 59 year old female receiving Voltaren (Diclofenac)

Reported by a physician from Japan on 2007-10-16

Patient: 59 year old female

Adverse reactions / side effects: Skin Exfoliation, Necrosis, Blood Albumin Decreased, Haematocrit Decreased, RED Blood Cell Count Decreased, C-Reactive Protein Increased, Gamma-Glutamyltransferase Increased, Blister, Lymphocyte Count Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Toxic Epidermal Necrolysis, Blood Cholinesterase Decreased, Protein Total Decreased, Haemoglobin Decreased, Rash Erythematous, Skin Erosion

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Lansoprazole
    Dosage: 60 mg/day
    Indication: Gastric Ulcer
    Start date: 2007-07-23
    End date: 2007-08-03

Lansoprazole
    Dosage: 30 mg/day
    Administration route: Oral
    Start date: 2007-08-04
    End date: 2007-08-21

Olmetec
    Dosage: unk, unk
    Administration route: Oral
    Start date: 2007-08-08
    End date: 2007-08-21

Apresolin
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-07-30
    End date: 2007-08-08

Voltaren
    Dosage: 25 mg/day
    Indication: Antipyresis
    Start date: 2007-07-23
    End date: 2007-08-05

Levofloxacin
    Dosage: 400 mg/day
    Administration route: Oral
    Indication: Infection
    Start date: 2007-08-08
    End date: 2007-08-12

Omegacin
    Dosage: 600 mg/day
    Indication: Interstitial Lung Disease
    Start date: 2007-07-23
    End date: 2007-08-04

Dormicum
    Dosage: 10 ug/day
    Indication: Sedation
    Start date: 2007-07-23
    End date: 2007-07-28

Pentazocine Lactate
    Dosage: 30 ug/day
    Indication: Sedation
    Start date: 2007-07-23
    End date: 2007-07-28

Prodif
    Dosage: 800 mg/day
    Start date: 2007-07-23
    End date: 2007-08-04

Prodif
    Dosage: 400 mg/day
    Start date: 2007-07-23
    End date: 2007-08-04

Baktar
    Dosage: 2 g/day
    Administration route: Oral
    Indication: Interstitial Lung Disease
    Start date: 2007-07-24
    End date: 2007-08-01

Norvasc
    Dosage: 5 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-08-08
    End date: 2007-08-21

Other drugs received by patient: Polymyxin B; Elaspol



Adverse event in male receiving Voltaren (Diclofenac)

Reported by a individual with unspecified qualification from Japan on 2007-10-12

Patient: male

Adverse reactions / side effects: Blood Urea Increased, Hyperkalaemia, Hypoglycaemia, Hyponatraemia, Acidosis, C-Reactive Protein Increased, Sepsis, Dehydration, Adrenal Insufficiency, Enteritis Infectious, Blood Creatinine Increased, Shock, Renal Failure Acute, Anuria

Adverse event resulted in: hospitalization

Suspect drug(s):
Voltaren (Diclofenac)



Adverse event in 55 year old female receiving Voltaren (Diclofenac)

Reported by a health professional (non-physician/pharmacist) from Norway on 2007-07-31

Patient: 55 year old female

Adverse reactions / side effects: Vomiting, Anaemia, Faeces Discoloured, Haematemesis, Haemoglobin Decreased, Diarrhoea, C-Reactive Protein Increased, Bacterial DNA Test Positive, Duodenal Ulcer Haemorrhage, Melaena, White Blood Cell Count Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Voltaren
    Dosage: 50 mg, tid
    Indication: Back Pain
    Start date: 2007-01-01
    End date: 2007-07-10

Mobic
    Dosage: 15 mg, bid
    Administration route: Oral
    End date: 2007-07-10

Other drugs received by patient: Surmontil; Paralgin Forte; Sobril; Sumatriptan Succinate



Adverse event in 61 year old female receiving Voltaren (Diclofenac)

Reported by a individual with unspecified qualification from Japan on 2007-07-16

Patient: 61 year old female, weighing 59.0 kg (129.8 pounds)

Adverse reactions / side effects: Blood Bilirubin Increased, Drug Eruption, Thoracic Cavity Drainage, Disseminated Intravascular Coagulation, Pyrexia, Erythema, Laboratory Test Abnormal, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Pleural Effusion, Blood Creatinine Increased, Lymphocyte Count Decreased, Oxygen Saturation Decreased, White Blood Cell Count Increased, Blood Urea Increased, Dyspnoea, Neutrophil Count Increased, Monocyte Count Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Urine Output Decreased, Lymphocyte Stimulation Test Positive, Rash Macular, Haemoglobin Decreased, Renal Failure, Aspartate Aminotransferase Increased, Oliguria, Platelet Count Decreased, Lung Infiltration

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Voltaren
    Dosage: 37.5 mg/day
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2005-11-09
    End date: 2005-11-10

Loxonin
    Dosage: 60 mg, tid
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2005-11-10
    End date: 2005-11-13

Dacarbazine
    Dosage: 180 mg/day
    Indication: Malignant Melanoma
    Start date: 2005-11-08
    End date: 2005-11-12

Nidran
    Dosage: 100 mg/day
    Indication: Malignant Melanoma
    Start date: 2005-11-08
    End date: 2005-11-08

Oncovin
    Dosage: 1 mg/day
    Indication: Malignant Melanoma
    Start date: 2005-11-08
    End date: 2005-11-08

Feron
    Dosage: 3000000 iu/day
    Indication: Malignant Melanoma
    Start date: 2005-11-08
    End date: 2005-11-12

Other drugs received by patient: Norvasc; Towamin; Lipitor; Voglibose



Adverse event in 94 year old female receiving Voltaren (Diclofenac)

Reported by a individual with unspecified qualification from France on 2007-06-25

Patient: 94 year old female

Adverse reactions / side effects: Back Pain, Blood Alkaline Phosphatase Increased, Dysphagia, Hypotension, Blood Lactate Dehydrogenase Increased, Disorientation, Pallor, Oesophageal Varices Haemorrhage, Haematemesis, Haemoglobin Decreased, Oesophagoscopy, C-Reactive Protein Increased, Oesophageal Variceal Ligation

Adverse event resulted in: hospitalization

Suspect drug(s):
Voltaren (Diclofenac)

Other drugs received by patient: Omeprazole; Vastarel; Lorazepam; Furosemide; Celectol; Prozac; Efferalgan Codeine; Delursan



Adverse event in 43 year old male receiving Voltaren (Diclofenac)

Reported by a physician from France on 2007-06-13

Patient: 43 year old male, weighing 72.0 kg (158.4 pounds)

Adverse reactions / side effects: Pancreatitis Acute, Abdominal Pain, Epigastric Discomfort, C-Reactive Protein Increased, Lipase Increased, Serum Ferritin Increased, White Blood Cell Count Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Voltaren (Diclofenac)

Other drugs received by patient: Alpha Amylase; Pivalone



Adverse event in 11 year old male receiving Voltaren (Diclofenac)

Reported by a individual with unspecified qualification from Japan on 2007-06-07

Patient: 11 year old male, weighing 32.0 kg (70.4 pounds)

Adverse reactions / side effects: Blood PH Increased, Disseminated Intravascular Coagulation, Blood Albumin Decreased, Petechiae, Pyrexia, Erythema, Blood Fibrinogen Decreased, Interstitial Lung Disease, C-Reactive Protein Increased, Acute Respiratory Distress Syndrome, Blood Creatinine Increased, White Blood Cell Count Increased, Cough, Renal Failure Acute, Hypertensive Encephalopathy, Dyspnoea, Blood Urea Increased, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Pancytopenia, Life Support, Rash, Protein Total Decreased, Lymphocyte Stimulation Test Positive, Aspartate Aminotransferase Increased, Platelet Count Decreased, PO2 Increased, Lung Infiltration, Calculus Ureteric

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Voltaren (Diclofenac)

Other drugs received by patient: Predonine; Bufferin; Sulpyrine; Kashilon; Cefazolin Sodium; Methylprednisolone 16mg TAB



Adverse event in 35 year old male receiving Voltaren (Diclofenac)

Reported by a individual with unspecified qualification from Japan on 2007-06-07

Patient: 35 year old male, weighing 64.0 kg (140.8 pounds)

Adverse reactions / side effects: Drug Eruption, Viral Infection, Rash Papular, Pyrexia, Eosinophil Count Increased, Erythema, Rash Pruritic, C-Reactive Protein Increased, Gamma-Glutamyltransferase Increased, Lymphocyte Count Decreased, White Blood Cell Count Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Voltaren
    Dosage: 37.5 mg, bid
    Administration route: Oral
    Indication: Arthralgia
    Start date: 2001-12-23
    End date: 2002-02-06

Selbex
    Dosage: .5 g, bid
    Administration route: Oral
    Indication: Prophylaxis Against Gastrointestinal Ulcer
    Start date: 2001-12-23
    End date: 2002-02-06

Voltaren
    Administration route: Topical

Adefuronic
    Indication: Hyperthermia
    Start date: 2002-02-18
    End date: 2002-02-18



Adverse event in 11 year old male receiving Voltaren (Diclofenac)

Reported by a individual with unspecified qualification from Japan on 2007-06-04

Patient: 11 year old male, weighing 32.0 kg (70.4 pounds)

Adverse reactions / side effects: Blood PH Increased, Disseminated Intravascular Coagulation, Petechiae, Blood Albumin Decreased, Blood Fibrinogen Decreased, C-Reactive Protein Increased, Acute Respiratory Distress Syndrome, Blood Creatinine Increased, White Blood Cell Count Increased, Renal Failure Acute, Cough, Dyspnoea, Blood Urea Increased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Pancytopenia, Protein Total Decreased, Lymphocyte Stimulation Test Positive, Rash, Aspartate Aminotransferase Increased, Platelet Count Decreased, PO2 Increased, Lung Infiltration, Calculus Ureteric

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Voltaren (Diclofenac)

Other drugs received by patient: Predonine; Bufferin; Sulpyrine; Kashilon; Cefazolin Sodium



Adverse event in 16 year old male receiving Voltaren (Diclofenac)

Reported by a physician from Japan on 2007-05-22

Patient: 16 year old male

Adverse reactions / side effects: Glucose-6-Phosphate Dehydrogenase Deficiency, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Protein Urine Present, Haematuria, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Pyrexia, Haemoglobin Decreased, Haematocrit Decreased, C-Reactive Protein Increased, Aspartate Aminotransferase Increased, Platelet Count Decreased, Haemolytic Anaemia, Influenza

Adverse event resulted in: hospitalization

Suspect drug(s):
Voltaren (Diclofenac)

Other drugs received by patient: Onon; Clarithromycin; Selbex; PL Gran.; Pansporin; Relenza; Calonal; Alpinyl; Miltax



Adverse event in 41 year old male receiving Voltaren (Diclofenac)

Reported by a physician from Japan on 2007-05-11

Patient: 41 year old male, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Brain Death, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Blood Calcium Increased, Pyrexia, C-Reactive Protein Increased, Brain Oedema, Blood Creatinine Increased, White Blood Cell Count Increased, Mydriasis, Brain Stem Haemorrhage, Blood Urea Increased, Dyspnoea, Urine Output Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Dependence ON Respirator, Haemodialysis, Brain Stem Syndrome, Dehydration, Aspartate Aminotransferase Increased, Platelet Count Decreased, Blood Pressure Decreased

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Voltaren (Diclofenac)

Other drugs received by patient: Adona; Transamin; Primperan INJ; Gaster; Glyceol



Adverse event in 94 year old female receiving Voltaren (Diclofenac)

Reported by a individual with unspecified qualification from France on 2007-04-30

Patient: 94 year old female

Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Back Pain, Dysphagia, Blood Lactate Dehydrogenase Increased, Hypotension, Disorientation, Pallor, Haematemesis, Haemoglobin Decreased, C-Reactive Protein Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Voltaren (Diclofenac)

Other drugs received by patient: Omeprazole; Vastarel; Temesta; Furosemide



Adverse event in 16 year old male receiving Voltaren (Diclofenac)

Reported by a physician from Japan on 2007-04-13

Patient: 16 year old male

Adverse reactions / side effects: Glucose-6-Phosphate Dehydrogenase Deficiency, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Protein Urine Present, Haematuria, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Pyrexia, Haemoglobin Decreased, Haematocrit Decreased, C-Reactive Protein Increased, Aspartate Aminotransferase Increased, Platelet Count Decreased, Haemolytic Anaemia, Influenza

Adverse event resulted in: hospitalization

Suspect drug(s):
Voltaren (Diclofenac)

Other drugs received by patient: Onon; Clarithromycin; Selbex; PL Gran.; Pansporin; Relenza; Calonal; Alpinyl; Miltax



Adverse event in 41 year old male receiving Voltaren (Diclofenac)

Reported by a physician from Japan on 2007-04-06

Patient: 41 year old male, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Brain Death, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Blood Calcium Increased, Pyrexia, C-Reactive Protein Increased, Brain Oedema, Blood Creatinine Increased, White Blood Cell Count Increased, Mydriasis, Brain Stem Haemorrhage, Blood Urea Increased, Dyspnoea, Urine Output Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Dependence ON Respirator, Haemodialysis, Brain Stem Syndrome, Dehydration, Aspartate Aminotransferase Increased, Platelet Count Decreased, Blood Pressure Decreased

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Voltaren (Diclofenac)

Other drugs received by patient: Adona; Transamin; Primperan INJ; Gaster; Glyceol



Adverse event in 91 year old female receiving Voltaren (Diclofenac)

Reported by a health professional (non-physician/pharmacist) from Norway on 2007-03-26

Patient: 91 year old female

Adverse reactions / side effects: Blood Calcium Increased, Drug Interaction, Platelet Count Increased, Constipation, Muscle Rigidity, Gastrointestinal Ulcer, Hypokinesia, C-Reactive Protein Increased, Methylmalonic Aciduria, Bacterial DNA Test Positive, Blood Sodium Decreased, Blood Creatinine Increased, Decreased Appetite, White Blood Cell Count Increased, Blood Iron Decreased, Endoscopy, Thyroxine Increased, Eating Disorder, Haematochezia, Blood Potassium Decreased, Mental Disorder, Tardive Dyskinesia, Alanine Aminotransferase Decreased

Adverse event resulted in: hospitalization

Suspect drug(s):
Voltaren
    Administration route: Oral
    End date: 2007-02-01

Prednisolone
    Dosage: unk, unk
    Administration route: Oral
    Indication: Myalgia
    Start date: 2006-12-01
    End date: 2007-02-01

Trilafon
    Dosage: 8 mg daily
    Administration route: Oral
    End date: 2007-02-25

Albyl-E
    Dosage: 160 mg daily
    Administration route: Oral

Other drugs received by patient: Plendil; Atacand HCT; Selo-ZOK



Adverse event in 39 year old male receiving Voltaren (Diclofenac)

Reported by a individual with unspecified qualification from France on 2007-03-20

Patient: 39 year old male

Adverse reactions / side effects: Pyoderma Gangrenosum, Staphylococcal Skin Infection, C-Reactive Protein Increased, Skin Ulcer, Rash Macular, Skin Nodule, Inflammation

Adverse event resulted in: hospitalization

Suspect drug(s):
Voltaren
    Dosage: 300 mg/day
    Administration route: Oral
    Indication: Spondylitis

Enbrel
    Dosage: 50 mg/week
    Indication: Spondylitis

Other drugs received by patient: Minocin



Adverse event in 41 year old male receiving Voltaren (Diclofenac)

Reported by a physician from Japan on 2007-03-16

Patient: 41 year old male, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Brain Death, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Blood Calcium Increased, Pyrexia, C-Reactive Protein Increased, Brain Oedema, Blood Creatinine Increased, White Blood Cell Count Increased, Mydriasis, Brain Stem Haemorrhage, Blood Urea Increased, Dyspnoea, Urine Output Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Dependence ON Respirator, Haemodialysis, Brain Stem Syndrome, Dehydration, Aspartate Aminotransferase Increased, Platelet Count Decreased, Blood Pressure Decreased

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Voltaren (Diclofenac)

Other drugs received by patient: Adona; Transamin; Primperan INJ; Gaster; Glyceol



Adverse event in 96 year old female receiving Voltaren (Diclofenac)

Reported by a individual with unspecified qualification from France on 2007-03-14

Patient: 96 year old female, weighing 55.0 kg (121.0 pounds)

Adverse reactions / side effects: Confusional State, Pyrexia, Pallor, Microcytic Anaemia, Haematemesis, C-Reactive Protein Increased, Hypoglycaemic Coma, Melaena, Hypertonia, Blood Glucose Increased, Blood Urea Increased, Hyponatraemia, Status Epilepticus, Protein Total Decreased, Hallucination, Visual, Psychomotor Skills Impaired, Peptic Ulcer Haemorrhage, Asthenia

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Kardegic
    Dosage: 75 mg, qd
    Administration route: Oral
    End date: 2006-11-08

Esomeprazole Magnesium
    Dosage: 1 df, cont (synringe pump)
    Start date: 2006-11-08
    End date: 2006-11-08

Esomeprazole Magnesium
    Dosage: 40 mg, bid
    Start date: 2006-11-09
    End date: 2006-11-13

Esomeprazole Magnesium
    Dosage: 40 mg, qd
    Administration route: Oral
    Start date: 2006-11-13

Voltaren
    Dosage: 75 mg, qd
    Administration route: Oral
    End date: 2006-11-08

Other drugs received by patient: Modopar; Trivastal; Daflon; Meteoxane; Movicol; Seresta



Adverse event in 96 year old female receiving Voltaren (Diclofenac)

Reported by a individual with unspecified qualification from France on 2007-03-13

Patient: 96 year old female, weighing 55.0 kg (121.0 pounds)

Adverse reactions / side effects: Confusional State, Pyrexia, Pallor, Microcytic Anaemia, Haematemesis, C-Reactive Protein Increased, Hypoglycaemic Coma, Melaena, Hypertonia, Blood Glucose Increased, Blood Urea Increased, Hyponatraemia, Status Epilepticus, Protein Total Decreased, Hallucination, Visual, Psychomotor Skills Impaired, Peptic Ulcer Haemorrhage, Asthenia

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Kardegic
    Dosage: 75 mg, qd
    Administration route: Oral
    End date: 2006-11-08

Esomeprazole Magnesium
    Dosage: 1 df, cont (synringe pump)
    Start date: 2006-11-08
    End date: 2006-11-08

Esomeprazole Magnesium
    Dosage: 40 mg, bid
    Start date: 2006-11-09
    End date: 2006-11-13

Esomeprazole Magnesium
    Dosage: 40 mg, qd
    Administration route: Oral
    Start date: 2006-11-13

Voltaren
    Dosage: 75 mg, qd
    Administration route: Oral
    End date: 2006-11-08

Other drugs received by patient: Modopar; Trivastal; Daflon; Meteoxane; Movicol; Seresta



Adverse event in 96 year old female receiving Voltaren (Diclofenac)

Reported by a individual with unspecified qualification from France on 2007-03-10

Patient: 96 year old female, weighing 55.0 kg (121.0 pounds)

Adverse reactions / side effects: Confusional State, Pyrexia, Pallor, Microcytic Anaemia, Haematemesis, C-Reactive Protein Increased, Hypoglycaemic Coma, Melaena, Hypertonia, Blood Glucose Increased, Blood Urea Increased, Hyponatraemia, Status Epilepticus, Protein Total Decreased, Hallucination, Visual, Psychomotor Skills Impaired, Peptic Ulcer Haemorrhage, Asthenia

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Kardegic
    Dosage: 75 mg, qd
    Administration route: Oral
    End date: 2006-11-08

Esomeprazole Magnesium
    Dosage: 1 df, cont (synringe pump)
    Start date: 2006-11-08
    End date: 2006-11-08

Esomeprazole Magnesium
    Dosage: 40 mg, bid
    Start date: 2006-11-09
    End date: 2006-11-13

Esomeprazole Magnesium
    Dosage: 40 mg, qd
    Administration route: Oral
    Start date: 2006-11-13

Voltaren
    Dosage: 75 mg, qd
    Administration route: Oral
    End date: 2006-11-08

Other drugs received by patient: Modopar; Trivastal; Daflon; Meteoxane; Movicol; Seresta



Adverse event in 96 year old female receiving Voltaren (Diclofenac)

Reported by a individual with unspecified qualification from France on 2007-02-22

Patient: 96 year old female, weighing 55.0 kg (121.0 pounds)

Adverse reactions / side effects: Confusional State, Pyrexia, Pallor, Microcytic Anaemia, Haematemesis, C-Reactive Protein Increased, Hypoglycaemic Coma, Melaena, Hypertonia, Blood Glucose Increased, Blood Urea Increased, Hyponatraemia, Status Epilepticus, Protein Total Decreased, Hallucination, Visual, Psychomotor Skills Impaired, Peptic Ulcer Haemorrhage, Asthenia

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Kardegic
    Dosage: 75 mg, qd
    Administration route: Oral
    End date: 2006-11-08

Esomeprazole Magnesium
    Dosage: 1 df, cont (synringe pump)
    Start date: 2006-11-08
    End date: 2006-11-08

Esomeprazole Magnesium
    Dosage: 40 mg, bid
    Start date: 2006-11-09
    End date: 2006-11-13

Esomeprazole Magnesium
    Dosage: 40 mg, qd
    Administration route: Oral
    Start date: 2006-11-13

Voltaren
    Dosage: 75 mg, qd
    Administration route: Oral
    End date: 2006-11-08

Other drugs received by patient: Modopar; Trivastal; Daflon; Meteoxane; Movicol; Seresta

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009